Skip to main content
Default Image

Perspectives: Pelosi’s Aggressive Drug Pricing Plan Doesn’t Even Have To Pass To Scare Pharma

Stat: Insulin Shows Why We Need A Public Option In The Pharma Industry: When Frederick Banting, Charles Best, and James Collip filed for a U.S. patent on insulin in 1923 and sold it to the University of Toronto for $1 each, they did it because, as Best once said, “insulin belongs to the world. ”They also believed that securing the patent was a form of publication, and wrote to the university president, “When the details of the method of preparation are published anyone would be free to prepare the extract, but no one could secure a profitable monopoly. ”Sadly, they were mistaken.” (Dana Brown and Elizabeth Pfiester, 9/10)

Publication date: 2019-09-10
Parent publication: Kaiser Health News
Publication URL: https://khn.org/morning-breakout/perspectives-pelosis-aggressive-drug-pricing-plan-doesnt-even-have-to-pass-to-scare-pharma/

More related work

Default Image

Healthcare as a public service: Redesigning U.S. healthcare with health and equity at the center

The Veterans Health Administration—the country’s only fully public, integrated healthcare system—has a lot to tell us about how a national healthcare service for the United States might operate.

read more
Default Image

Preston is putting socialist policies into practice

Labor movements must pursue a social and economic vision that can address the deep structural inequalities these pandemic years have exposed. Preston gives a glimpse of the exciting possibilities that collaboration with unions could achieve.

read more
Default Image

This must be the year of climate action—we've wasted so many

The climate issue has grown too large and devastating to ignore. We need the demand for action raised to the highest decibel our civil society can generate.

read more